fda_recall · drug_recall · high

Ajanta Pharma Ltd. — Class II recall: Duloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: A…

Event date
2026-05-13 00:00:00Z
Observed
2026-07-09 22:51:42Z
Source ID
D-0515-2026
Payload hash
a34d5047bebe073e50f24e3e

Summary

CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals. Status: Ongoing.

Informational only. Not legal, financial, or medical advice.